IMMUNOHISTOCHEMICAL DETECTION OF p53 PROTEIN OVEREXPRESSION VERSUS GENE SEQUENCING IN URINARY BLADDER CARCINOMAS
- 1 October 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 162 (4) , 1496-1501
- https://doi.org/10.1016/s0022-5347(05)68347-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Relationship of p53 and bcl-2 to Prognosis in Muscle-Invasive Transitional Cell Carcinoma of the BladderJournal of Urology, 1996
- p53 Mutations and Prognosis in Bladder TumorsJournal of Urology, 1995
- Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 AmplificationJNCI Journal of the National Cancer Institute, 1994
- P53 expression, ploidy and progression in pTl transitional cell carcinoma of the bladderBritish Journal of Urology, 1994
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992
- The p53 tumour suppressor geneNature, 1991
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984